Literature DB >> 17717366

Challenges of implementing human papillomavirus (HPV) vaccination policy.

Angela E Raffle1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17717366      PMCID: PMC1952478          DOI: 10.1136/bmj.39273.458322.BE

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  18 in total

1.  Comparisons of cervical cancer screening programmes in the European Union.

Authors:  A Linos; E Riza
Journal:  Eur J Cancer       Date:  2000-11       Impact factor: 9.162

2.  Vaccination against human papillomaviruses shows great promise.

Authors:  Matti Lehtinen; Jorma Paavonen
Journal:  Lancet       Date:  2004 Nov 13-19       Impact factor: 79.321

3.  The current status of HPV and rotavirus vaccines in national immunisation schedules in the EU--preliminary results of a VENICE survey.

Authors:  Y Kudjawu; D Lévy-Bruhl; L Pastore Celentano; D O'Flanagan; S Salmaso; P Lopalco; N Mullins; S Bacci
Journal:  Euro Surveill       Date:  2007-04-26

4.  Cancer of the cervix: death by incompetence.

Authors: 
Journal:  Lancet       Date:  1985-08-17       Impact factor: 79.321

5.  Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes.

Authors:  Loretta Brabin; Stephen A Roberts; Farah Farzaneh; Henry C Kitchener
Journal:  Vaccine       Date:  2006-02-09       Impact factor: 3.641

6.  Accelerated decline in cervical cancer mortality in England and Wales.

Authors:  P Sasieni; J Cuzick; E Farmery
Journal:  Lancet       Date:  1995-12-09       Impact factor: 79.321

7.  Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics.

Authors:  M Quinn; P Babb; J Jones; E Allen
Journal:  BMJ       Date:  1999-04-03

8.  Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented.

Authors:  A E Raffle; B Alden; M Quinn; P J Babb; M T Brett
Journal:  BMJ       Date:  2003-04-26

9.  Vaccines for prevention of human papillomavirus infection.

Authors:  V Foerster; J Murtagh
Journal:  Issues Emerg Health Technol       Date:  2005-12

10.  HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial.

Authors:  H C Kitchener; M Almonte; P Wheeler; M Desai; C Gilham; A Bailey; A Sargent; J Peto
Journal:  Br J Cancer       Date:  2006-06-13       Impact factor: 7.640

View more
  20 in total

1.  Do you approve of spending $300 million on HPV vaccination?: no.

Authors:  Abby Lippman; Madeline Boscoe; Carol Scurfield
Journal:  Can Fam Physician       Date:  2008-02       Impact factor: 3.275

2.  Human papillomavirus vaccination programmes.

Authors:  Bernard Lo
Journal:  BMJ       Date:  2007-08-25

3.  Commentary: Health inequity could increase in poor countries if universal HPV vaccination is not adopted.

Authors:  Eduardo L Franco
Journal:  BMJ       Date:  2007-08-25

4.  Correspondence (letter to the editor): Vaccination is No Substitute for Early Detection?

Authors:  Christian Weymayr
Journal:  Dtsch Arztebl Int       Date:  2009-02-20       Impact factor: 5.594

5.  Gardasil® - The New HPV Vaccine: The Right Product, the Right Time? A Commentary.

Authors:  Joel Lexchin; Neil Arya; Sonal Singh
Journal:  Healthc Policy       Date:  2010-05

6.  HPV Vaccination in Bangladesh: Ethical Views.

Authors:  Marium Salwa; Tarek Abdullah Al-Munim
Journal:  Recent Results Cancer Res       Date:  2021

7.  Novel human papilloma virus (HPV) genotypes in children with recurrent respiratory papillomatosis.

Authors:  Ioannis N Mammas; George Sourvinos; Elena Vakonaki; Panagiota Giamarelou; Catherine Michael; Demetrios A Spandidos
Journal:  Eur J Pediatr       Date:  2010-03-07       Impact factor: 3.183

Review 8.  Human papilloma virus (HPV) vaccination in childhood: challenges and perspectives.

Authors:  I Mammas; F Maher; M Theodoridou; D Spandidos
Journal:  Hippokratia       Date:  2011-10       Impact factor: 0.471

Review 9.  Human papilloma virus (HPV) infection in children and adolescents.

Authors:  Ioannis N Mammas; George Sourvinos; Demetrios A Spandidos
Journal:  Eur J Pediatr       Date:  2008-12-03       Impact factor: 3.183

10.  Would Worldwide Vaccination of Both Males and Females Against the Human Papillomavirus be a Worthy Investment?

Authors:  Kush Patel
Journal:  Mcgill J Med       Date:  2009-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.